Form 4: Magnera Director Granted 5,871 Prorated RSUs

Magnera Corp director Michael S. Curless received a prorated grant of 5,871 RSUs on November 14, 2025 that vests in full on November 14, 2026 to align director awards with the 2026 Annual Shareholder Meeting.

Summary

• Director Michael S. Curless was granted 5,871 Restricted Stock Units (RSUs) on 2025-11-14.
• The award is a prorated portion of the Annual Director Award intended to bridge from the 2024 RSU lapse (reported 2025-11-04) to the 2026 Annual Shareholder Meeting.
• The RSUs vest in full one year from the grant date, on 2026-11-14.
• Upon vesting, the RSUs represent 5,871 shares of Magnera Corp common stock (par value $0.01) with no exercise price.
• Following the transaction, 5,871 derivative securities (RSUs) are beneficially owned directly by the director.
• Directors are expected to receive a full 2026 Annual Director Award at the 2026 Annual Shareholder Meeting upon reelection.
• RSUs have no value until all restrictions lapse on the final vesting date.
• The Form 4 was signed by attorney-in-fact on 2025-11-18.

Sentiment

Score: 5

Explanation: Routine director equity grant with minor dilution and clear vesting; neutral impact on fundamentals.

Positives

• No insider sales; the transaction is an equity grant that supports director alignment and retention.
• Clear alignment of director equity grant timing with the Annual Shareholder Meeting cadence.
• Simple, one-year vesting schedule (full vest on 2026-11-14) provides transparent timing.
• Directors anticipate a full 2026 Annual Director Award upon reelection, indicating continuity of the compensation program.

Negatives

• Potential dilution upon vesting of 5,871 shares.
• No immediate economic value to the director until vesting; RSUs carry restriction risk until 2026-11-14.

Risks

• RSUs have no value until all restrictions lapse on the final vesting date.
• A full 2026 Annual Director Award is contingent on director reelection at the 2026 Annual Shareholder Meeting.

Future Outlook

Directors are expected to receive a full 2026 Annual Director Award at the 2026 Annual Shareholder Meeting upon reelection; the current 2025 prorated award vests in full on 2026-11-14.

Management Comments

• The grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse (reported 2025-11-04) and the 2026 Annual Shareholder Meeting.
• The 2025 Prorated Director Award vests in full one year from the grant date.
• RSUs have no value until all restrictions lapse on the final vesting date.

Industry Context

Board-level equity compensation via annual RSU grants with approximately one-year vesting is standard among U.S. public companies, and prorated awards are commonly used to align grant timing with annual meeting cycles or partial-year service.

Comparison to Industry Standards

• Grant structure aligns with common S&P 500 practice where director RSUs typically vest at the next annual meeting or after one year (e.g., boards at Microsoft, JPMorgan, and Coca-Cola use annual equity awards with ~1-year vesting).
• Prorated director awards to align grant timing with the annual meeting are standard across large-cap and mid-cap issuers; similar alignment steps are frequently disclosed in director compensation policies at peers like Intel and Salesforce.

Corporate Governance

Related Party Transactions

• Grant of 5,871 RSUs to Director Michael S. Curless as part of director compensation; underlying 5,871 common shares (par value $0.01); no exercise price; direct ownership.

Stakeholder Impact

• Shareholders: minor dilution upon vesting of 5,871 shares.
• Directors: strengthened alignment and retention via one-year vesting equity award.
• Governance: compensation cycle synchronized with the Annual Shareholder Meeting.

Next Steps

• RSUs vest in full on 2026-11-14.
• Full 2026 Annual Director Award expected at the 2026 Annual Shareholder Meeting upon director reelection.

Key Dates

Keywords

Magnera Corp, MAGN, Form 4, Restricted Stock Units, Director Compensation, Insider Transaction, Beneficial Ownership, Equity Award, Vesting, Annual Shareholder Meeting, Corporate Governance